Clinical Trial Update: Aimovig Pregnancy Exposure Registry

View source ↗

Summary

Amgen is conducting a pregnancy exposure registry for Aimovig (erenumab) to study its safety in pregnancy among migraine patients; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AIMOVIG (ERENUMAB-AOOE)

Snippet

Sponsor: Amgen | Conditions: Migraine | Status: RECRUITING